Commerce Dashboard

Go Back

Serum Institute could export 20-30 million vaccine doses a month to COVAX: Adar Poonawalla

IBEF:  October 22, 2021

According to Mr. Adar Poonawalla, CEO, Serum Institute of India (SII) stated that they could export 20 million to 30 million doses of the AstraZeneca shot to the WHO-backed global platform COVAX this year and then several more from January.

Mr. Adar Poonawalla stated that the company's production of the vaccine could rise to 240 million doses a month from ~ 220 million currently. He also added that SII will make only the single-dose Sputnik Light vaccine from Russia and not the two-dose Sputnik V.

SII could also produce 50 million to 100 million doses of the Novavax vaccine by December, Mr. Poonawalla added further.

Disclaimer: This information has been collected through secondary research and IBEF is not responsible for any errors in the same.